- Home
- TNGX vs KBSX Comparison
TNGX vs KBSX Comparison
Compare TNGX & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | KBSX |
|---|---|---|
| Founded | 2014 | 1976 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 62.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TNGX | KBSX |
|---|---|---|
| Price | $8.80 | $1.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 6.8K |
| Earning Date | 11-04-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $66,501,000.00 | $44,890,395.00 |
| Revenue This Year | $53.01 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 53.29 | 30.46 |
| 52 Week Low | $1.03 | $1.26 |
| 52 Week High | $11.20 | $15.48 |
Technical Indicators
Market Signals| Indicator | TNGX | KBSX |
|---|---|---|
| Relative Strength Index (RSI) | 45.67 | 41.15 |
| Support Level | $8.42 | $1.31 |
| Resistance Level | $10.08 | $1.60 |
| Average True Range (ATR) | 0.59 | 0.04 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 18.56 | 4.35 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About KBSX FST Corp. Ordinary Shares
FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.